Suci Ventasamia

Dr. Suci Ventasamia


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2026 in Organoids
Verified
Journal Article
Open access
PDF file
Henkie Isahwan Ahmad Mulyadi LaiHenkie Isahwan Ahmad Mulyadi Lai
Henkie Isahwan Ahmad Mulyadi Lai
RIRickie Isahdie
Rickie Isahdie
SVSuci Ventasamia
Suci Ventasamia
SPSukrit Promtang
Sukrit Promtang
Natural products offer diverse chemical structures and pharmacological activities for therapeutic discovery. Their translation benefits from evidence that connects a reproducible preparation with relevant exposure and a clearly defined biological response. Organoids can strengthen this evidence by providing tissue architecture, cellular diversity, and donor-specific features suited to focused experimental questions. This critical narrative review uses a structured literature search to synthesize representative natural-product studies across tumor, intestinal, hepatic, renal, pulmonary, cortical, retinal, and cardiac platforms. Direct organoid evidence, findings from related three-dimensional models, and prospective applications are distinguished by material, species, derivation, exposure, and endpoint. The selected examples illustrate these distinctions rather than provide a comprehensive evidence map. We propose an exposure-aware conceptual decision framework linking material identity, assay compatibility, exposure plausibility, model fitness, functional activity, and context-specific validation. Six gates guide advance, iterate, or stop/redirect decisions and make the evidence supporting each claim explicit. The framework provides a practical structure for study design and reporting, with prospective evaluation as the next step. Roselle serves as an illustrative botanical example for future organoid testing. Used alongside analytical studies, two-dimensional cultures, animal models, and clinical research, qualified organoids can help move natural-product discovery toward reproducible, tissue-level, and decision-relevant evidence.